RA Capital Management, L.P. 13D/13G Filings for Olema Pharmaceuticals, Inc. (OLMA)

RA Capital Management, L.P. 13D and 13G filings for Olema Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-11-14
4:43 pm
Unchanged
2022-11-14 13G Olema Pharmaceuticals, Inc.
OLMA
RA Capital Management, L.P. 0
0.000%
0
(Unchanged)
Filing
2022-05-16
4:30 pm
Sale
2022-05-16 13G Olema Pharmaceuticals, Inc.
OLMA
RA Capital Management, L.P. 0
0.000%
-2,150,404decrease
(Position Closed)
Filing
2022-02-14
4:11 pm
Unchanged
2021-12-31 13G Olema Pharmaceuticals, Inc.
OLMA
RA Capital Management, L.P. 2,150,404
5.300%
0
(Unchanged)
Filing
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Olema Pharmaceuticals, Inc.
OLMA
RA Capital Management, L.P. 2,150,404
5.400%
2,150,404increase
(New Position)
Filing